The finding that blocking the H3R by CPX in the presence of TNFα enhanced cell differentiation, is also in line with studies on cancer cells reporting that inhibition of histamine receptor H3 suppresses the growth and metastasis in human non-small cell lung cancer cells (Zhao et al., 2020) thus potentially promoting differentiation. Here, HRH3 is linked to cancer.